Abstract: A method for inducing an activity of a user's autonomic nervous system is provided. The method includes steps of: (a) on condition that each of the user's reference heart rate information corresponding to each of active states of the user's autonomic nervous system is obtained, an inducing device, if a specific active state of the autonomic nervous system is selected by the user, acquiring first reference heart rate information of the user corresponding to the specific active state of the autonomic nervous system; and (b) the inducing device supporting a first vibration stimulus with a first period corresponding to the first reference heart rate information to be applied to the user, to thereby allow the user's real-time average cardiac interval to be synchronized with the first vibration stimulus.

Abstract: Provided herein is a built-in speaker module. The built-in speaker module is installed in a housing of an electronic device having a first bottom surface spaced apart from a ground and a second bottom surface installed above the first bottom surface, and includes a speaker installed above the second bottom surface, a first vibration absorbing member interposed between the speaker and the second bottom surface, and a second vibration absorbing member interposed between the first bottom surface and the second bottom surface, wherein sound is emitted from the speaker through openings formed in the first bottom surface and the second bottom surface.

Abstract: The present invention relates to a system for providing nutritional balance based on pet health information, and more particularly, to a system for providing nutritional balance based on pet health information, which determines the amount of supply of a recipe in consideration of pet information, such as the kind, a growth stage, and an activity stage of a pet, and the amount of motion of a pet obtained from a sensor attached to a pet, thereby providing an optimum recipe and amount.

Abstract: The present invention relates to a composition for suppressing chronic obstructive pulmonary disease (COPD) comprising a Pistacia weinmannifolia extract, a fraction thereof, or a compound isolated therefrom and, more particularly, to a pharmaceutical composition for preventing or treating COPD comprising a Pistacia weinmannifolia extract, a fraction thereof, or a compound isolated therefrom; a food composition for preventing or improving COPD, and the compound isolated therefrom. The composition comprising a Pistacia weinmannifolia extract, a fraction thereof, or a compound isolated therefrom, according to the present invention, is not toxic, suppresses the invasion of inflammatory cells into the bronchial tube of a COPD-induced animal model, and effectively suppresses the expression of CXCL-1, TNF-?, or MIP-2.

Abstract: Provided is a method for treating a symptom of vibrio infection by using an RTX toxin production inhibitor comprising N-(4-oxo-4H-thieno[3,4-c]chromen-3-yl)-3-phenylprop-2-ynamide having derivatives thereof which can repress (prevent or treat) a symptom of vibrio infection by inhibiting RTX toxin production, other than directly killing vibrio bacteria, to not allow vibrio bacteria to have pathogenicity, and thereby can be an alternative to antibiotics that aim to kill bacteria themselves and thus fundamentally retain the problem of resistance incurrence.

Abstract: The present invention relates to a composition for preventing or treating asthma comprising a Pistacia weinmannifolia J. Poiss. ex Franch extract or a fraction thereof. The Pistacia weinmannifolia J. Poiss. ex Franch extract or the fraction thereof according to the present invention does not exhibit toxicity, inhibits the generation of NO, IL-4, IL-5, and IL-13 and the generation of reactive oxygen species in the bronchial tubes, and has significantly induced the alleviation of airway hyperresponsiveness, inhibition of the infiltration of inflammatory cells into the bronchial tubes, and reduction of inflammatory cells in bronchoalveolar lavage fluid in an ovalbumin-induced asthma mouse model. In addition, the Pistacia weinmannifolia J. Poiss.

Abstract: The present invention relates to a pharmaceutical composition and a food composition containing Portulaca grandiflora Hook. extract or a fraction thereof as an active ingredient for preventing, treating or ameliorating neuroinflammation or neuro-degenerative diseases. The Portulaca grandiflora Hook. extract or a fraction thereof according to the present invention is derived from a natural product which has been in use as a natural medicinal ingredient, and as such, has no side effects and inhibits expression of NO, PGE2, iNOS and/or COX-2 genes or protein, which are factors associated with inflammation, and is additionally superbly effective for increasing and improving memory and the ability to learn, and thus can be beneficially used to prevent or treat neuroinflammation or neuro-degenerative diseases.

Abstract: The present invention relates to a thermotherapy bed, and more specifically, to a slide-type thermotherapy bed, of which an air massage module is easy to store and use and which is used in thermotherapy. The thermotherapy bed of the present invention includes a body in which a thermotherapy device is installed, an auxiliary unit sliding on the body to be unfolded or overlap the body, such that the thermotherapy device is opened or closed, a mat configured to cover an upper portion of the auxiliary unit, and an air massage module installed in the mat and stored in the auxiliary unit.

Abstract: A thermo-therapeutic apparatus is provided. The thermo-therapeutic apparatus according to one embodiment of the present disclosure includes a first supporting plate having a plurality of through holes formed therein and formed of skin foam; a front cover disposed on the first supporting plate so that one side of the first supporting plate is exposed, and to which the first supporting plate is coupled; a plurality of ceramics each insertion-fixed to the plurality of through holes, and each configured to protrude to the outside of the first supporting plate to a predetermined height; a heater disposed on one sides of the plurality of ceramics and configured to heat the plurality of ceramics; a second supporting plate disposed on one side of the heater and including a vibrator; and a rear cover disposed on one side of the second supporting plate and coupled to the front cover.

Abstract: A method for inducing an activity of a user's autonomic nervous system is provided. The method includes steps of: (a) on condition that each of the user's reference heart rate information corresponding to each of active states of the user's autonomic nervous system is obtained, an inducing device, if a specific active state of the autonomic nervous system is selected by the user, acquiring first reference heart rate information of the user corresponding to the specific active state of the autonomic nervous system; and (b) the inducing device supporting a first vibration stimulus with a first period corresponding to the first reference heart rate information to be applied to the user, to thereby allow the user's real-time average cardiac interval to be synchronized with the first vibration stimulus.

Abstract: In order to maximize spatial utilization and to minimize the volume of a thermotherapy bed so that the thermotherapy bed can be easily stored or moved, the thermotherapy bed includes: a bed body having a thermotherapy device placed therein; side frames connected to both side surfaces of the bed body, respectively; and bed legs configured to support the bed body and connected to the side frames, respectively, wherein the thermotherapy device is placed in a center of the bed body and forms a protrusion on a bottom surface of the bed body, and the bed legs are folded to face an inside of the bed body and are accommodated in spaces formed at both sides of the thermotherapy device.

Abstract: Provided is an apparatus for processing a substrate. The apparatus includes a chamber providing an inner space in which a process with respect to the substrate is performed, a susceptor disposed in the inner space and on which the substrate is placed, a fixing plate disposed in an exhaust port disposed in a sidewall of the chamber along a circumference of the susceptor, the fixing plate having a plurality of through-holes, and at least one sliding plate disposed on an upper or lower portion of the fixing plate to rotate with respect to a center of the susceptor, the at least one sliding plate selectively opening and closing the through-holes.

Abstract: Disclosed is a massage apparatus including oscillators which receive supplied power and oscillate under control of a controller. Here, two oscillators installed to allow oscillation directions thereof to be at right angle are included, and the controller sequentially controls power supplied to the two oscillators to perform oscillations in an order of a bowel movement direction.

Abstract: Disclosed is a method for an electronic device. The method may include: acquiring a galvanic skin response; generating a first parameter for a first interval and a second parameter for a second interval based on the galvanic skin response, the second interval being an interval before the first interval; determining a first threshold corresponding to the first interval based on the second parameter; and determining an activity state of the first interval based on the first threshold and the first parameter corresponding to the first interval.

Abstract: The present invention relates to a pharmaceutical composition and a food composition containing Portulaca grandiflora Hook. extract or a fraction thereof as an active ingredient for preventing, treating or ameliorating neuroinflammation or neuro-degenerative diseases. The Portulaca grandiflora Hook. extract or a fraction thereof according to the present invention is derived from a natural product which has been in use as a natural medicinal ingredient, and as such, has no side effects and inhibits expression of NO, PGE2, iNOS and/or COX-2 genes or protein, which are factors associated with inflammation, and is additionally superbly effective for increasing and improving memory and the ability to learn, and thus can be beneficially used to prevent or treat neuroinflammation or neuro-degenerative diseases.

Abstract: Multilingual information guidance system and device are provided. To elaborate, the system may include: at least one information output device configured to display guidance information to a user; and an information provision server connected to the information output device and configured to provide guidance information prepared in one or more languages to the information output device according to a request of the information output device. The information output device may output guidance information prepared in the native language corresponding to nationality information of a user, which is read from an RFID tag in which the nationality information of the user is stored or transmitted from the information provision server.

Abstract: There are provided a printed circuit board and a manufacturing method thereof. The printed circuit board includes: a core layer having a cavity provided therein; an electronic component included in the cavity; a conductive partition disposed on a side of the cavity; and insulating layers disposed on and below the core layer.

Abstract: The present invention relates to a composition for preventing or treating asthma comprising a Pistacia weinmannifolia J. Poiss. ex Franch extract or a fraction thereof. The Pistacia weinmannifolia J. Poiss. ex Franch extract or the fraction thereof according to the present invention does not exhibit toxicity, inhibits the generation of NO, IL-4, IL-5, and IL-13 and the generation of reactive oxygen species in the bronchial tubes, and has significantly induced the alleviation of airway hyperresponsiveness, inhibition of the infiltration of inflammatory cells into the bronchial tubes, and reduction of inflammatory cells in bronchoalveolar lavage fluid in an ovalbumin-induced asthma mouse model. In addition, the Pistacia weinmannifolia J. Poiss.

Abstract: A Spirulina maxima extract of the present invention and Allophycocyanin (APC), R-phycoerythrin (R-PE), and C-phycocyanin (C-PC), which are components of the Spirulina maxima extract, show an effect of inhibiting cell death and A2E (pyridinium bis-retinoid), oxidation due to blue light, and therefore can be usefully applied as an active ingredient in a composition for preventing and treating retinal disease.

Abstract: The present invention relates to a pharmaceutical composition for preventing or treating inflammatory diseases or asthma comprising a Lagerstroemia ovalifolia extract or a fraction thereof as an active ingredient, and a health functional food and a feed additive for preventing or improving inflammatory diseases or asthma comprising the extract or the fraction as an active ingredient.